Objectives: A 5-year observation study investigated the quality of life and intervention rates following the Thermablate thermal balloon endometrial ablation (Thermablate EA) and the NovaSure radiofrequency impedance-based ablation (Novasure).Methods: Anonymous information for the study was gathered from 'NOTIS', the electronic system used within our Trust to hold patient data. Following the ablation subsequent procedures that occurred were listed as well as the bleeding pattern recorded.Results: There were 123 women treated with the Novasure system and 168 women with Thermablate EA. A greater number of women treated with the Novasure system became amenorrheic (64%) compared to the Thermablate EA group (24%). However more women who were treated with the Novasure system compared to the Thermablate EA suffered post ablation pain, (13.8% and 1.8%) and remained unsatisfied. In the Novasure group, 67.8 % had no subsequent interventions as compared to 75.6 % in the Thermablate EA group (p=.001). In the Thermablate EA group, 7% had subsequent medical treatment compared to 12% of the NEA women. There are more women opted for hysterectomy in the Novasure group (20.3%) as compared to 8.3% in the Thermablate EA. The odds ratio of women having hysterectomy after the Novasure as compared to Thermablate EAS group is 2.8 (95% CI = 1.37 -5.71). Conclusion:Women may prefer the Thermablate EA with the associated less medical intervention and hysterectomy rates despite more women becoming amenorrheic after a Novasure treatment. This has implications on cost and patient satisfaction when deciding on initial treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.